Search research articles
Contact Us
Filters
Showing results (541-550 of 577) with videos related to
Page
of 58
Sort By:
Vaccines
|
September 28, 2017
Microcrystalline Tyrosine (MCT<sup>®</sup>): A Depot Adjuvant in Licensed Allergy Immunotherapy Offers New Opportunities in Malaria
Gustavo Cabral-Miranda, Matthew D Heath, Ariane C Gomes, et al.
Anticancer Research
|
June 10, 2010
Overexpression of p150, a part of the large subunit of the eukaryotic translation initiation factor 3, in colon cancer
J Haybaeck, T O'Connor, R Spilka, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 22, 2015
Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes
Claudia Cavelti-Weder, Katharina Timper, Eleonora Seelig, et al.
European Journal of Immunology
|
July 19, 2012
Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8⁺ T-cell responses in melanoma patients
Simone M Goldinger, Reinhard Dummer, Petra Baumgaertner, et al.
Allergy
|
October 10, 2023
Influence of antigen density and TLR ligands on preclinical efficacy of a VLP-based vaccine against peanut allergy
Pascal S Krenger, Romano Josi, Jan Sobczak, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
June 24, 2011
The second-generation active Aβ immunotherapy CAD106 reduces amyloid accumulation in APP transgenic mice while minimizing potential side effects
Christoph Wiessner, Karl-Heinz Wiederhold, Alain C Tissot, et al.
The Journal of Allergy and Clinical Immunology
|
May 7, 2019
Immunization of cats to induce neutralizing antibodies against Fel d 1, the major feline allergen in human subjects
Franziska Thoms, Gary T Jennings, Melanie Maudrich, et al.
Immunity
|
April 23, 2005
CCL19 and CCL21 induce a potent proinflammatory differentiation program in licensed dendritic cells
Benjamin J Marsland, Patrick Bättig, Monika Bauer, et al.
Plos One
|
August 11, 2017
Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles
Marika Doucet, Aadil El-Turabi, Franziska Zabel, et al.
The Journal of Experimental Medicine
|
April 1, 1996
LFA-1-deficient mice show normal CTL responses to virus but fail to reject immunogenic tumor
R Schmits, T M Kündig, D M Baker, et al.
Page
of 58
Search research articles
Search
Showing results (541-550 of 577) with videos related to
Sort By:
Page
of 58
Vaccines
|
September 28, 2017
Microcrystalline Tyrosine (MCT<sup>®</sup>): A Depot Adjuvant in Licensed Allergy Immunotherapy Offers New Opportunities in Malaria
Gustavo Cabral-Miranda, Matthew D Heath, Ariane C Gomes, et al.
Anticancer Research
|
June 10, 2010
Overexpression of p150, a part of the large subunit of the eukaryotic translation initiation factor 3, in colon cancer
J Haybaeck, T O'Connor, R Spilka, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 22, 2015
Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes
Claudia Cavelti-Weder, Katharina Timper, Eleonora Seelig, et al.
European Journal of Immunology
|
July 19, 2012
Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8⁺ T-cell responses in melanoma patients
Simone M Goldinger, Reinhard Dummer, Petra Baumgaertner, et al.
Allergy
|
October 10, 2023
Influence of antigen density and TLR ligands on preclinical efficacy of a VLP-based vaccine against peanut allergy
Pascal S Krenger, Romano Josi, Jan Sobczak, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
June 24, 2011
The second-generation active Aβ immunotherapy CAD106 reduces amyloid accumulation in APP transgenic mice while minimizing potential side effects
Christoph Wiessner, Karl-Heinz Wiederhold, Alain C Tissot, et al.
The Journal of Allergy and Clinical Immunology
|
May 7, 2019
Immunization of cats to induce neutralizing antibodies against Fel d 1, the major feline allergen in human subjects
Franziska Thoms, Gary T Jennings, Melanie Maudrich, et al.
Immunity
|
April 23, 2005
CCL19 and CCL21 induce a potent proinflammatory differentiation program in licensed dendritic cells
Benjamin J Marsland, Patrick Bättig, Monika Bauer, et al.
Plos One
|
August 11, 2017
Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles
Marika Doucet, Aadil El-Turabi, Franziska Zabel, et al.
The Journal of Experimental Medicine
|
April 1, 1996
LFA-1-deficient mice show normal CTL responses to virus but fail to reject immunogenic tumor
R Schmits, T M Kündig, D M Baker, et al.
Page
of 58